Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Share · CNE100001R58 (XSHE)

Overview

No Price

Closing Price XSHE 09.12.2025: 30,08 CNY

09.12.2025 07:04

Current Prices from Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
SHENZHEN STOCK EXCHANGE	300357.SZ	CNY	09.12.2025 07:04	30,08 CNY	-0,28 CNY -0,92 %

Share Float & Liquidity

Free Float 49,96 %

Shares Float 261,6 M

Shares Outstanding 523,58 M

Invested Funds

The following funds have invested in Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.:

Fund iShares MSCI China UCITS ETF USD (Dist)	Vol. in million 0,31	Percentage (%) 0,0094 %

Company Profile for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Share

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and sells pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. It also offers skin care and stem cells series. The company is headquartered in Huzhou, China.

Get up to date insights from finAgent about Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Company Data

Name Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Company Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Website https://www.wolwobiotech.com

Primary Exchange

SHENZHEN STOCK EXCHANGE

ISIN CNE100001R58

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - General

CEO Jianming He

Market Capitalization 16 Mrd.

Country China

Currency CNY

Employees 1,7 T

Address No. 636, Zhiyuan North Road, 313200 Huzhou

IPO Date 2014-01-21

Ticker Symbols

Name	Symbol
SHENZHEN STOCK EXCHANGE	300357.SZ

More Shares

Investors who hold Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. also have the following shares in their portfolio:

ORANGE 20/27 MTN Bond

PNC FINANCIAL S 22/UND. Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog